Emerson Arcoverde Nunes

Dr. Emerson Arcoverde Nunes

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2023 in European Neuropsychopharmacology
Verified
Journal Article
Closed access
MFMarcelo Falchi-Carvalho
Marcelo Falchi-Carvalho
IWIsabel Wießner
Isabel Wießner
SSSérgio Ruschi Bergamachi Silva
Sérgio Ruschi Bergamachi Silva
LMLucas O. Maia
Lucas O. Maia
HBHandersson Barros
Handersson Barros
FPFernanda Palhano-Fontes
Fernanda Palhano-Fontes

15 June 2024 in Journal of Psychiatric Research
Verified
Journal Article
Closed access
ELEduardo Igor Torquato Cardoso Lopes
Eduardo Igor Torquato Cardoso Lopes
PCPatrícia Cavalcanti-Ribeiro
Patrícia Cavalcanti-Ribeiro
FPFernanda Palhano-Fontes
Fernanda Palhano-Fontes
KGKaike Thiê da Costa Gonçalves
Kaike Thiê da Costa Gonçalves
ENEmerson Arcoverde Nunes
Emerson Arcoverde Nunes
NGNicole Leite Galvão-Coelho
Nicole Leite Galvão-Coelho

1 September 2012 in Brazilian Journal of Psychiatry
Verified
Journal Article
Open access
ENEmerson Arcoverde Nunes
Emerson Arcoverde Nunes
LCLeila Canever
Leila Canever
LOLarissa de Oliveira
Larissa de Oliveira
RLRenata D’aLtoe de Luca
Renata D’aLtoe de Luca
JQJoão Quevedo
João Quevedo
JHJaime Eduardo C. Hallak
Jaime Eduardo C. Hallak
The aim of this study is to investigate the effects of pregabalin on the behavior of rats under the influence of ketamine, an NMDA receptor antagonist that mimics the symptoms of schizophrenia. Rats were injected with saline or 25 mg/kg ketamine intraperitoneally. After that, behavior modifications were investigated by the evaluation of stereotypy and hyperlocomotion, after treating rats with pregabalin (at doses of 30 mg/kg or 100 mg/kg) or placebo (saline solution). The administration of pregabalin reduced ketamine-induced hyperlocomotion. However, neither doses of pregabalin had a significant effect on ketamineinduced stereotypy. This is the first study to investigate the effects of pregabalin using an animal model of psychosis. Furthermore, our results indicate that behavioral changes induced by ketamine in rats can be reversed with the use of pregabalin, suggesting its potential to treat psychotic symptoms.


19 February 2025 in Journal of Psychiatric Research
Verified
Journal Article
Closed access
VTVagner Deuel de O. Tavares
Vagner Deuel de O. Tavares
FSFelipe B. Schuch
Felipe B. Schuch
GSGeovan Menezes de Sousa
Geovan Menezes de Sousa
MHMats Hallgren
Mats Hallgren
MTMegan Teychenne
Megan Teychenne
NGNicole Leite Galvão-Coelho
Nicole Leite Galvão-Coelho

5 August 2012 in Psychopharmacology
Verified
Journal Article
Closed access
PDF file
ENEmerson Arcoverde Nunes
Emerson Arcoverde Nunes
RFRafael Freire
Rafael Freire
MRMoema dos Reis
Moema dos Reis
ASAdriana Cardoso de Oliveira e Silva
Adriana Cardoso de Oliveira e Silva
SMSergio Machado
Sergio Machado
ANAntonio E. Nardi
Antonio E. Nardi